U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083830) titled 'ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants' on July 09.
Brief Summary: This is a phase 1 trial, 36 month duration for subjects with end-stage renal disease (ESRD). The objectives of the trail are1) Determine the safety of ECP-DL cell infusion in living donor renal transplant recipients. 2) Determine rates of graft rejection and compare to historical controls.
One week prior to planned LDK transplant the donor and recipient pair will be seen for ECP-DL preparation and infusion. Donors will undergo one single unstimulated peripheral blood mononuclear cell collection using the THERAKOS(R) CELLEX(R) Pho...